Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director

Actinium Pharmaceuticals, Inc. (ATNM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/19/2022 4 SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 300,000 shares @ $0
07/01/2022 4 O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 256,438 options to buy @ $0
07/01/2022 4 Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 72,156 options to buy @ $0
07/01/2022 4 Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 72,156 options to buy @ $0
07/01/2022 4 Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 72,156 options to buy @ $0
07/01/2022 4 SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 827,366 options to buy @ $0
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Chell Jeffrey W. (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 18,351 options to buy @ $0
09/03/2021 4 Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 67,164 options to buy @ $0
09/03/2021 4 Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 18,351 options to buy @ $0
09/03/2021 4 O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 107,463 options to buy @ $0
09/03/2021 4 Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 18,351 options to buy @ $0
09/03/2021 4 SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 310,182 options to buy @ $0
09/03/2021 4 Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 18,351 options to buy @ $0
08/14/2020 4 O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 59,066 options to buy @ $0
08/14/2020 4 SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 139,062 options to buy @ $0
08/14/2020 4 Chell Jeffrey W. (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 8,333 options to buy @ $0
08/14/2020 4 Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 46,667 options to buy @ $0
08/14/2020 4 Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 8,333 options to buy @ $0
08/14/2020 4 Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 8,333 options to buy @ $0
08/14/2020 4 Ludwig Dale L. (Chief Science & Tech. Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $0
08/14/2020 4 Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 8,333 options to buy @ $0
07/16/2019 4 Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 250,000 options to buy @ $0.232, valued at $58k
07/16/2019 4 Chell Jeffrey W. (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 250,000 options to buy @ $0.232, valued at $58k
07/16/2019 4 Ludwig Dale L. (Chief Scientific Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 400,000 options to buy @ $0.232, valued at $92.8k
07/16/2019 4 O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 400,000 options to buy @ $0.232, valued at $92.8k
07/16/2019 4 Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 400,000 options to buy @ $0.232, valued at $92.8k
07/16/2019 4 SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 1,500,000 options to buy @ $0.232, valued at $348k
07/16/2019 4 Kapur Anil (Chief Commercial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 400,000 options to buy @ $0.232, valued at $92.8k
07/16/2019 4 Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 250,000 options to buy @ $0.232, valued at $58k
07/16/2019 4 Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Granted 250,000 options to buy @ $0.232, valued at $58k
03/07/2019 4 Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 3,500 shares @ $0.6, valued at $2.1k
02/21/2019 4 SETH SANDESH (Chairman & CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 8,125 shares @ $0.6, valued at $4.9k
12/10/2018 4 SETH SANDESH (Chairman & CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.
Txns: Bought 10,000 shares @ $0.4372, valued at $4.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy